Cargando…
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
BACKGROUND: Berberine is an isoquinoline alkaloid extracted from various Berberis species which is widely used in East Asia for a wide range of symptoms. Recently, neuroprotective effects of berberine in Alzheimer’s disease (AD) animal models are being extensively reported. So far, no clinical trial...
Autores principales: | Yuan, Ning-Ning, Cai, Cui-Zan, Wu, Ming-Yue, Su, Huan-Xing, Li, Min, Lu, Jia-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533761/ https://www.ncbi.nlm.nih.gov/pubmed/31122236 http://dx.doi.org/10.1186/s12906-019-2510-z |
Ejemplares similares
-
Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease
por: Wang, Lin, et al.
Publicado: (2022) -
Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies
por: Hao, Yanwei, et al.
Publicado: (2022) -
Role of berberine in Alzheimer’s disease
por: Cai, Zhiyou, et al.
Publicado: (2016) -
Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology
por: Yuan, Ning-Ning, et al.
Publicado: (2019) -
Mercury-induced neurotoxicity and neuroprotective effects of berberine
por: Moneim, Ahmed E. Abdel
Publicado: (2015)